Related Experiment Video

Updated: Dec 3, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.7K

lncRNA MRUL Suppressed Non-Small Cell Lung Cancer Cells Proliferation and Invasion by Targeting miR-17-5p/SRSF2 Axis

Ying Chen1, Tianle Shen2, Xuping Ding3

  • 1Department of Radiation Oncology, Zhejiang Key Laboratory of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital); Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, 1 Banshandong Road, 310022 hangzhou, Zhejiang, China.

Biomed Research International
|October 30, 2020
PubMed

Insights

A novel long noncoding RNA, MRUL, is overexpressed in non-small cell lung cancer (NSCLC) and promotes tumor progression. Targeting MRUL could offer new therapeutic and diagnostic strategies for NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
  • Long noncoding RNAs (lncRNAs) play crucial roles in cancer development and progression.
  • The specific roles of many lncRNAs in NSCLC remain to be fully elucidated.

Purpose of the Study:

  • To identify and characterize a novel lncRNA, MRUL, in the context of non-small cell lung cancer (NSCLC).
  • To investigate the regulatory mechanisms and functional significance of MRUL in NSCLC progression.
  • To evaluate MRUL as a potential therapeutic target and diagnostic biomarker for NSCLC.

Main Methods:

  • Bioinformatic analysis to predict the functions of MRUL.
  • Experimental validation including gene knockdown and cell-based assays (proliferation, invasion, migration).
  • Investigation of the molecular interaction between MRUL, miR-17, and SRSF2.

Main Results:

  • MRUL was found to be significantly overexpressed in NSCLC tissues and associated with poor patient prognosis.
  • Knockdown of MRUL suppressed NSCLC cell proliferation, invasion, and migration.
  • MRUL promotes NSCLC progression by sponging miR-17, leading to increased SRSF2 expression.

Conclusions:

  • MRUL functions as an oncogenic lncRNA in non-small cell lung cancer.
  • The MRUL/miR-17/SRSF2 axis represents a novel regulatory pathway in NSCLC.
  • MRUL holds potential as a diagnostic biomarker and therapeutic target for NSCLC.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

910

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K